固定剂量的obicetrapib和ezetimibe用于降低LDL胆固醇 (TANDEM):一个3期随机,双盲,安慰剂对照试验
Ashish Sarraju1, Danielle Brennan1, Kierstyn Hayden1
1Department of Cardiovascular Medicine and Cleveland Clinic Coordinating Center for Clinical Research, Cleveland Clinic, Cleveland, OH, USA.
Lancet (London, England)
|May 10, 2025
概括
固定剂量联合使用的obicetrapib和ezetimibe显著降低了LDL胆固醇. 这种口服疗法为患有动脉样硬化心血管疾病 (ASCVD) 的高风险患者提供了一个有前途的新选择.
科学领域:
- 心血管医学
- 药理学
- 临床试验
背景情况:
- 增加的LDL胆固醇是动脉样硬化心血管疾病 (ASCVD) 的主要驱动因素.
- 有效降低LDL胆固醇对于预防ASCVD事件至关重要.
- 需要新的治疗策略来优化脂质管理.
研究的目的:
- 评估固定剂量组合 (FDC) 的LDL胆固醇降低效果.
- 为了比较FDC与obicetrapib或ezetimibe单一治疗和安慰剂的疗效.
主要方法:
- 这是一项随机双盲试验,涉及407名具有高ASCVD风险或异位家族高胆固醇血症的参与者.
- 参与者每天接受FDC (10 mg的obicetrapib+10 mg的ezetimibe),10 mg的obicetrapib单独治疗,10 mg的ezetimibe单独治疗或安慰剂治疗.
- 与安慰剂和单一治疗组相比,共同主要的终点是LDL胆固醇的百分比变化.
主要成果:
- 与安慰剂相比,FDC显示LDL胆固醇的显著降低为-48. 6% (p< 0. 001).
- 与以塞蒂米布单一治疗相比,FDC的降低率更高,为-27. 9% (p< 0. 001).
- 与安慰剂 (p< 0. 001) 相比,欧比单独治疗降低了31. 9%的LDL胆固醇,所有活性治疗组的安全性概况相似.
结论:
- 固定的剂量组合可显著降低LDL胆固醇.
- 这种口服单片药物治疗在治疗高脂血症和预防ASCVD方面具有潜在的价值.
- 对于需要更强烈地降低LDL胆固醇的患者,FDC提供了有效的治疗选择.
相关概念视频
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
492
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
492
Phase I Oxidative Reactions: Overview
220
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
220
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Drug Metabolism: Phase I Reactions
2.9K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
2.9K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K


